Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples